Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference37 articles.
1. Abad S, Vega A, Hernandez E, Merida E, de Sequera P, Albalate M, et al. Universal sustained viral response to the combination of ombitasvir/paritaprevir/ritonavir and dasabuvir with/without ribavirin in patients on hemodialysis infected with hepatitis C virus genotypes 1 and 4. Am J Nephrol. 2017;45(3):267–72. https://doi.org/10.1159/000454819 .
2. Center for Disease Control and Prevention. Surveillance for viral hepatitis—United States, 2015. United States: CDC; 2015.
3. Shiffman ML. Chronic hepatitis C virus: advances in treatment, promise for the future. New York: Springer; 2011.
4. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558–67.
5. Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006;23(8):1055–65. https://doi.org/10.1111/j.1365-2036.2006.02889.x .
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献